FEATURED CONTENT

• Building Trust Through Connection: EmVenio At The Atlanta Black Expo

  Engaging with communities in familiar settings helps raise awareness, address concerns, and create a more inclusive foundation for clinical research participation built on dialogue, respect, and long‑term relationships.

• Rethinking Trial Access Through Trust-Driven Design And Local Collaboration

  Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.

• Balancing Patient Centricity With Complexity In Cancer Trials

  By bringing clinical research closer to where patients live and receive care, sponsors and CROs can expand reach, reduce travel burdens, and engage populations historically underrepresented in cancer studies.

• Community Connections: Leveraging Localized Patient Access In Clinical Trials

  This roundtable brought together several experts to discuss how expanding community-based research can transform clinical trial recruitment and representation.

• How Community-Based Research Models Expand Access

  As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's?

• DCTs And Community-Based Research Execution And Compliance

  The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.

• Debunking 5 Misconceptions About Community-Based Research Sites

  By confronting misconceptions about community-based research, we uncover evidence of how sites effectively manage complex trials while maintaining high standards of care.

• The Benefits Of Using Community Research In Obesity And Diabetes Trials

  The obesity drug development landscape is rapidly evolving, but despite this promising trajectory, significant barriers in patient recruitment and retention persist.

• Where Precision Meets Personal Connection

  Robert Lohayza, a Certified Mobile Research Nurse (CMRN), shares his experience and underscores the essential role of mobile clinicians in advancing global clinical research.

• Understanding The FDA's Push For More Representation In Clinical Trials

  Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.

• Why You Should Include SDOH In Clinical Trial Recruitment

  Embrace a broader approach to diversity in clinical trials by addressing social determinants of health and designing inclusive studies that ensure equitable representation and access to all patients.

• Survey Says Mobile Nurse Visits Have A Place In Clinical Trials

  Discover how mobile visits are transforming clinical trials by reducing barriers to participation, enhancing diversity, and bringing studies closer to patients and their communities.